Bis-Tetrahydrofuran: a Privileged Ligand for Darunavir and a New Generation of HIV Protease Inhibitors That Combat Drug Resistance.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 939, doi. 10.1002/cmdc.200600103
- By:
- Publication type:
- Article
Works matching IS 18607179 AND DT 2006 AND VI 1 AND IP 9
Results: 17
1
2
Correlation of Biological Activity with Active Site Binding Modes of Geminal Disulfone HIV-1 Integrase Inhibitors.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 959, doi. 10.1002/cmdc.200600040
- By:
- Publication type:
- Article
3
Ligand-Based Virtual Screening, Parallel Solution-Phase and Microwave-Assisted Synthesis as Tools to Identify and Synthesize New Inhibitors of Mycobacterium tuberculosis.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 973, doi. 10.1002/cmdc.200600026
- By:
- Publication type:
- Article
4
Graphical Abstract: ChemMedChem 9/2006.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 911, doi. 10.1002/cmdc.200690033
- Publication type:
- Article
5
Use of Triplet Excited States for the Study of Drug Binding to Human and Bovine Serum Albumins.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 1015, doi. 10.1002/cmdc.200600061
- By:
- Publication type:
- Article
6
Conformationally Constrained CCK8 Analogues Obtained from a Rationally Designed Peptide Library as Ligands for Cholecystokinin Type B Receptor.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 997, doi. 10.1002/cmdc.200600054
- By:
- Publication type:
- Article
7
Cover Picture: Synthesis and Biological Evaluation of a Multiantigenic Tn/TF-Containing Glycopeptide Mimic of the Tumor-Related MUC1 Glycoprotein (ChemMedChem 9/2006).
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 909, doi. 10.1002/cmdc.200690032
- By:
- Publication type:
- Article
8
Platensimycin, a New Antibiotic and 'Superbug Challenger' from Nature.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 951, doi. 10.1002/cmdc.200600145
- By:
- Publication type:
- Article
9
Structure-Activity Relationship Studies on the Immune Stimulatory Effects of Base-Modified CpG Toll-Like Receptor 9 Agonists.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 1007, doi. 10.1002/cmdc.200600064
- By:
- Publication type:
- Article
10
Preview: ChemMedChem 9/2006.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 1030, doi. 10.1002/cmdc.200690031
- Publication type:
- Article
11
Determination of the Bound Conformation of a Competitive Nanomolar Inhibitor of Mycobacterium tuberculosis Type II Dehydroquinase by NMR Spectroscopy.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 990, doi. 10.1002/cmdc.200600100
- By:
- Publication type:
- Article
12
Synthesis and Biological Evaluation of a Multiantigenic Tn/TF-Containing Glycopeptide Mimic of the Tumor-Related MUC1 Glycoprotein.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 965, doi. 10.1002/cmdc.200600104
- By:
- Publication type:
- Article
13
Probing, Inhibition, and Crystallographic Characterization of Metallo-β-lactamase (IMP-1) with Fluorescent Agents Containing Dansyl and Thiol Groups.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 969, doi. 10.1002/cmdc.200600115
- By:
- Publication type:
- Article
14
Prediction of ADMET Properties.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 920, doi. 10.1002/cmdc.200600155
- By:
- Publication type:
- Article
15
Rational Design of Aziridine-Containing Cysteine Protease Inhibitors with Improved Potency: Studies on Inhibition Mechanism.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 1021, doi. 10.1002/cmdc.200600081
- By:
- Publication type:
- Article
16
Identification of a Potent Agonist of the Orphan Nuclear Receptor Nurr1.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 955, doi. 10.1002/cmdc.200600078
- By:
- Publication type:
- Article
17
From our sister journals: ChemMedChem 9/2006.
- Published in:
- ChemMedChem, 2006, v. 1, n. 9, p. 916, doi. 10.1002/cmdc.200690034
- Publication type:
- Article